BackEagle Pharmaceuticals Overview

Eagle Pharmaceuticals Total Revenue

Revenue analysis for EGRX.

Quarterly Revenue

$64.65M
↓ 12.8% YoY

As of Jun 2023

Annual Revenue (TTM)

$257.55M
↓ 5.38% YoY

Trailing 12 months ending Jun 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin